全文获取类型
收费全文 | 8331篇 |
免费 | 795篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 230篇 |
妇产科学 | 158篇 |
基础医学 | 1080篇 |
口腔科学 | 119篇 |
临床医学 | 927篇 |
内科学 | 1659篇 |
皮肤病学 | 90篇 |
神经病学 | 661篇 |
特种医学 | 286篇 |
外科学 | 1606篇 |
综合类 | 204篇 |
一般理论 | 26篇 |
预防医学 | 853篇 |
眼科学 | 72篇 |
药学 | 556篇 |
中国医学 | 51篇 |
肿瘤学 | 506篇 |
出版年
2023年 | 56篇 |
2022年 | 60篇 |
2021年 | 125篇 |
2020年 | 119篇 |
2019年 | 172篇 |
2018年 | 198篇 |
2017年 | 147篇 |
2016年 | 161篇 |
2015年 | 152篇 |
2014年 | 233篇 |
2013年 | 344篇 |
2012年 | 527篇 |
2011年 | 506篇 |
2010年 | 272篇 |
2009年 | 260篇 |
2008年 | 483篇 |
2007年 | 439篇 |
2006年 | 398篇 |
2005年 | 436篇 |
2004年 | 388篇 |
2003年 | 332篇 |
2002年 | 318篇 |
2001年 | 236篇 |
2000年 | 256篇 |
1999年 | 202篇 |
1998年 | 86篇 |
1997年 | 77篇 |
1996年 | 92篇 |
1995年 | 69篇 |
1994年 | 81篇 |
1993年 | 70篇 |
1992年 | 124篇 |
1991年 | 153篇 |
1990年 | 104篇 |
1989年 | 103篇 |
1988年 | 122篇 |
1987年 | 145篇 |
1986年 | 124篇 |
1985年 | 107篇 |
1984年 | 68篇 |
1983年 | 59篇 |
1982年 | 42篇 |
1980年 | 47篇 |
1979年 | 68篇 |
1978年 | 46篇 |
1977年 | 55篇 |
1976年 | 38篇 |
1975年 | 41篇 |
1974年 | 49篇 |
1972年 | 42篇 |
排序方式: 共有9135条查询结果,搜索用时 15 毫秒
21.
An expression library was constructed by inserting cDNA copied from mRNA of the blood stages of Babesia bovis isolate KA into bacteriophage lambda gt11-amp3. An antigen-positive cDNA clone detected by screening the library with antibodies from cattle vaccinated with the KA isolate was shown to encode part of a high-molecular weight polypeptide antigen of B. bovis. This molecule was a dominant immunogen and was found by immunofluorescence to be within the parasite in infected erythrocytes. 相似文献
22.
23.
Despite advances in the neuro-imaging of the brain stem, an accurate diagnosis of intrinsic lesions in this region requires tissue sampling and histological verification. We have performed a series of computer-directed stereotactic procedures in 12 patients with intrinsic brain stem lesions. A positive diagnosis was obtained in 11 cases and therapeutic intervention was possible in four. There was no operative mortality. Because of the importance of an accurate diagnosis in order to avoid inappropriate therapy, together with the relative safety of the technique, computer-directed stereotactic biopsy should be considered in all patients harbouring an intrinsic brain stem mass. 相似文献
24.
Dr. Stanford S. Jhee Pharm.D. Dr. Jack W. Kern Pharm.D. Dr. Jin-Pil Burm Ph.D. Dr. Albert E. Yellin M.D. Dr. Mark A. Gill Pharm.D. FASHP FCCP 《Pharmacotherapy》1995,15(4):472-478
Study Objective . To determine the appropriate compartmental and noncompartmental pharmacokinetic parameters for intravenous piperacillin and tazobactam. Design . Sequential selection of patients entered into a randomized, open-label clinical efficacy trial. Setting . Los Angeles County-University of Southern California Medical Center. Participants . Sequential sample of 18 patients admitted for intraabdominal infections and consented into a comparative antibiotic trial. Interventions . Patients received piperacillin 4 g plus tazobactam 500 mg by intravenous intermittent infusion every 8 hours. Measurements and Main Results . The estimated noncompartmental pharmacokinetic parameters (mean ± SD) for piperacillin and tazobactam, respectively, were as follows: maximum concentration in plasma 218.7 ± 48.9 μg/ml and 27.8 ± 9.1 μg/ml; half-life 1.07 ± 0.22 hours and 1.00 ± 0.27 hours; elimination rate constant 0.67 ± 0.13 hr−1 and 0.73 ± 0.18 hr−1; area under the concentration-time curve from zero hour to infinity 288.5 ± 71.25 mg·hr/L and 36.3 ± 9.55 mg·hr/L; total plasma clearance 14.75 ± 3.93 L/hour and 14.78 ± 4.39 L/hour; renal clearance 5.69 ± 1.94 L/hour and 7.85 ± 3.37 L/hour; volume of distribution at steady state 21.00 ± 4.18 L and 22.47 ± 8.27 L; and mean residence time 1.72 ± 0.29 hours and 1.79 ± 0.35 hours. Conclusion . Our findings were similar to those in other surgical patient models. The two-compartmental model best described piperacillin and tazobactam disposition in our patients. Bayesian analyses of the two-compartment models of piperacillin and tazobactam were able to predict trough, peak, and 2-hour postadministration levels without bias. 相似文献
25.
26.
27.
An electrophysiological investigation of the properties of a murine recombinant 5-HT3 receptor stably expressed in HEK 293 cells. 总被引:2,自引:2,他引:0 下载免费PDF全文
1. The pharmacological and biophysical properties of a recombinant 5-HT3 receptor have been studied by use of patch-clamp techniques applied to HEK 293 cells stably transfected with the murine 5-HT3 R-A cDNA. 2. At a holding potential of -60 mV, 77% of cells investigated responded to ionophoretically applied 5-HT with an inward current. Such currents were unaffected by methysergide (1 microM), or ketanserin (1 microM), but were antagonized in a concentration-dependent and reversible manner by the selective 5-HT3 receptor antagonist, ondansetron (IC50 = 440 pM) and the non-selective antagonists (+)-tubocurarine (IC50 = 1.8 nM) and metoclopramide (IC50 50 nM). 3. The 5-HT-induced current reversed in sign (E5-HT) at approximately -2mV and exhibited inward rectification. The influence of extra- and intracellular ion substitutions upon E5-HT indicates the 5-HT-evoked current to be mainly mediated by a mixed monovalent cation conductance. 4. Calcium and magnesium (0.1-10 nM) produced a concentration-dependent, voltage-independent, inhibition of the 5-HT-induced response. Zinc (0.3-300 microM) exerted a biphasic effect with low concentrations enhancing, and high concentrations depressing, the 5-HT-evoked current. 5. Fluctuation analysis of inward currents evoked by a low (1 microM) concentration of 5-HT suggests the current to be mediated by the opening of channels with a conductance of 420 fS. 6. The pharmacological and biophysical properties of the 5-HT3 R-A are similar to those previously described for 5-HT3 receptors native to murine neuroblastoma cell lines, with the exception that the function of the recombinant receptor was enhanced by low concentrations of zinc. This observation suggests that the properties of the native receptor are not completely represented by the 5-HT3 R-A subunit alone. 相似文献
28.
Actions and mechanisms of action of novel analogues of sotalol on guinea-pig and rabbit ventricular cells. 下载免费PDF全文
1. The actions and mechanisms of action of novel analogues of sotalol which prolong cardiac action potentials were investigated in guinea-pig and rabbit isolated ventricular cells. 2. In guinea-pig and rabbit cells the compounds significantly prolonged action potential duration at 20% and 90% repolarization levels without affecting resting membrane potential. In guinea-pig but not rabbit cells there was an increase in action potential amplitude and in rabbit cells there was no change in the shape or position of the 'notch' in the action potential. 3. Possible mechanisms of action were studied in more detail in the case of compound II (1-(4-methanesulphonamidophenoxy)-3-(N-methyl 3,4 dichlorophenylethylamino)-2-propanol). Prolongation of action potential duration continued to occur in the presence of nisoldipine, and calcium currents recorded under voltage-clamp conditions were not reduced by compound II (1 microM). Action potential prolongation by compound II was also unaffected in the presence of 10 microM tetrodotoxin. 4. Compound II (1 microM) did not influence IK1 assessed from the current during ramp changes in membrane potential (20 mV s-1) over the range -90 to -10 mV. 5. Compound II (1 microM) blocked time-dependent delayed rectifier potassium current (IK) activated by step depolarizations and recorded as an outward tail following repolarization. When a submaximal concentration (50 nM) was applied there was no change in the apparent reversal potential of IK.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
29.
Trang T. Duong Joanne St. Louis Joseph J. Gilbert Fred D. Finkelman Gill H. Strejan 《Journal of neuroimmunology》1992,36(2-3)
SJL/J mice challenged with myelin basic protein (MBP) in complete Freund's adjuvant (CFA) developed only mild chronic-relapsing experimental allergic encephalomyelitis (EAE) with very low incidence. However, treatment of challenged mice with anti-infeferonγ (IFN-γ) monoclonal antibody (mAb) determined severe disease in all cases. Similarly, in passive EAE, the addition of anti-IFN-γ to the in vitro MBP-activated cells at the time of transfer led to significant disease exacerbation in all recipients. The disease enhancing effect was observed only when the mAb was given at the time of active challenge or of passive transfer, but not at later times. Anti-interleukin-2 (IL-2) antibody had only a marginal effect in the active induction, but drastically reduced the manifestations of passive EAE, even when mixed with a disease-enhancing dose of anti-IFN-γ. These findings support the notion that IL-2 is required for disease induction whereas IFN-γ plays a disease-limiting role early in the development of EAE. 相似文献
30.